Edition:
India

GlaxoSmithKline Consumer Healthcare Ltd (GLSM.NS)

GLSM.NS on National Stock Exchange of India

6,743.10INR
14 Aug 2018
Change (% chg)

Rs57.60 (+0.86%)
Prev Close
Rs6,685.50
Open
Rs6,685.50
Day's High
Rs6,797.70
Day's Low
Rs6,602.35
Volume
15,021
Avg. Vol
19,579
52-wk High
Rs6,950.00
52-wk Low
Rs4,851.00

Select another date:

Fri, May 11 2018

BRIEF-India's Glaxosmithkline Consumer Healthcare March-Qtr Profit Rises

* MARCH QUARTER PROFIT 2.12 BILLION RUPEES VERSUS PROFIT OF 1.76 BILLION RUPEES LAST YEAR

GSK buys out Novartis in $13 billion consumer healthcare shake-up

FRANKFURT/ZURICH GlaxoSmithKline is buying Novartis out of their consumer healthcare joint venture for $13 billion, taking full control of products including Sensodyne toothpaste, Panadol headache tablets, muscle gel Voltaren, and Nicotinell patches. | Video

GSK buys out Novartis in $13 billion consumer healthcare shake-up

FRANKFURT/ZURICH GlaxoSmithKline is buying Novartis out of their consumer healthcare joint venture for $13 billion, taking full control of products including Sensodyne toothpaste, Panadol headache tablets, muscle gel Voltaren, and Nicotinell patches. | Video

UPDATE 4-GSK buys out Novartis in $13 bln consumer healthcare shake-up

* Deal unravels JV agreed in 2014 (Adds fund manager quote, background on new Novartis CEO)

MEDIA-India's GlaxoSmithKline Consumer Healthcare to enter protein supplement segment - Mint

- Note: Reuters has not verified this story and does not vouch for its accuracy

Select another date: